Phibro Animal Health Corporation

Phibro Animal Health Corporation is an animal health and mineral nutrition company that develops, manufactures, and markets a wide range of products for food and companion animals. Its offerings include antibacterials, anticoccidials, nutritional specialties, vaccines, and vaccine adjuvants aimed at improving animal health, performance, food safety, and welfare. The company also produces trace mineral formulations (zinc, copper, manganese, iron) to fortify livestock feed and maintain optimal trace element balance. Additionally, Phibro engages in microbial and bioproduct development for animal health, nutrition, environmental, industrial, and agricultural applications. Through its Performance Products segment, it supplies specialty ingredients for personal care, industrial chemicals, and chemical catalysts. The company serves integrated poultry, swine, and cattle producers, as well as commercial feed manufacturers and wholesalers.

Phibro Animal Health Corporation is listed on the Nasdaq Global Market (NasdaqGM) under the ticker symbol PAHC. Its shares are traded in US dollars (USD), reflecting its primary listing in the United States. The company's financial reporting and stock price are denominated in USD, making it accessible to investors on US exchanges.

Phibro Animal Health Corporation operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. This classification reflects its focus on developing and manufacturing pharmaceutical and nutritional products for animals, including generic and specialty drugs. As a specialty drug manufacturer, Phibro produces a variety of animal health products such as antibacterials, anticoccidials, and vaccines, which are essential for treating and preventing diseases in livestock and companion animals. The company also falls under the broader healthcare umbrella due to its emphasis on animal health and nutrition, which directly impacts food safety and public health.

Phibro Animal Health Corporation operates across multiple regions globally, including the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company's headquarters are in the United States, and it serves customers through local sales offices in these regions. Its products reach integrated poultry, swine, and cattle producers, as well as commercial animal feed manufacturers and wholesalers. The geographic diversity allows Phibro to address the needs of animal agriculture and companion animal markets worldwide, leveraging its expertise in animal health, mineral nutrition, and specialty ingredients.

Phibro Animal Health Corporation organizes its business into three segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets products such as antibacterials, anticoccidials, nutritional specialties, vaccines, and vaccine adjuvants for food and companion animals, focusing on health, performance, and food safety. The Mineral Nutrition segment produces trace mineral formulations (zinc, copper, manganese, iron) to fortify livestock feed and maintain optimal trace element balance. The Performance Products segment offers specialty ingredients for personal care, industrial chemicals, and chemical catalysts. This diversified portfolio allows Phibro to serve a broad customer base across animal agriculture, industrial, and consumer markets.